Skip to main content
SpringerLink
Log in

Symptomkontrolle

  • Chapter
Palliativmedizin

  • 5785 Accesses

Zusammenfassung

Oft leiden Palliativpatienten mehr unter belastenden Symptomen als unter Schmerzen. Atemnot ist zuerst ein subjektives Gefühl, dessen Schwere nur Patienten selbst beurteilen können. Eine sorgfältige Ursachensuche ist angezeigt. Übelkeit und Erbrechen können ebenso verschiedene Gründe haben, sei es im Verdauungstrakt, Stoffwechselentgleisungen, im Gehirn oder als Medikamentennebenwirkung. Ein häufiges Problem stellt die Obstipation dar, wozu individuell angepasste und richtlinientreue Behandlungskonzepte dargestellt werden. Intestinale Obstruktion und Hyperkalzämie können zu schwerer Symptomlast führen, die differenziert anzugehen ist. Sehr belastend für Patienten, Angehörige und die Pflege ist ein terminales Delir, das ebenfalls sehr häufig auftritt.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  • Adams L, Chronos N, Lane G, Guz A (1985) The measurement of breathlessness induced in normal subjects: validity of two scaling techniques. Clin Sci (Lond) 69:7–16

    Google Scholar 

  • Akechi T, UchitomiY, Okumura H (1996) Usage of haloperidol for delirium in cancer patients. Support Cancer Care 4:390–392

    Google Scholar 

  • Allard P, Lamontagne C, Bernard P, Trenblay C (1999) How effective are supplementary doses of opioids for dyspnea in terminally ill cancer patients. J Pain Symptom Manage 17:256–265

    Google Scholar 

  • Alt-Epping B, Sitte T, Nauck F, Radbruch L (2010) Sedierung in der Palliativmedizin. Z Palliativmed 11:112–122

    Google Scholar 

  • American Psychiatric Association (1994) Diagnostic and statistical Manual of Mental disorders. APA, Washington DC

    Google Scholar 

  • Anti M, Pignataro G, Armuzzi A et al (1998) Water supplementation enhances the effect of high fiber diet on stool frequency and laxative consumption in adult patients with functional constipation. Hepatogastroenterology 45:727

    Google Scholar 

  • AWMF (2013) S2k-Leitlinie Chronische Obstipation, aktueller Stand: 02/2013. Register-Nr. 021/019

    Google Scholar 

  • AWMF (2015) S3-Leitlinie Palliativmedizin für Patienten mit einer nicht heilbaren Krebserkrankung, Version 1.0 – Mai 2015. Register-Nr: 128/001OL

    Google Scholar 

  • Bausewein C, Booth S, Gysels M, Kühnbach R, Higginson IJ (2010) Effectiveness of a hand-held fan for breathlessness: a randomised phase II trial. BMC Palliat Care doi: 10.1186/1472-684X-9-22

  • Body JJ, Bartl R, Bruckhardt P et al (1998) Current use of bisphosphonates in oncology. J Clin Oncol 16(12):3890–3899

    Google Scholar 

  • Borg GA (1982) Psychophysical bases of perceived exertion. Med Sci Sports Exerc 14:377–781

    Google Scholar 

  • Breitbart W, Marotty R, Platt M (1996) A double-blind comparison trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients. Am J Psychiatry 153:231–237

    Google Scholar 

  • Breitbart W (2001) Diagnosis and management of delirium in the terminally ill. In: Portenoy, Bruera E, (eds) Topics in Palliative care, Vol5. Oxford University Press, New York, pp 303–321

    Google Scholar 

  • Bruera E, Fainsinger R, Miller M, Kuehn N (1992) The assessment of pain intensity in patients with cognitive failure J Pain Symp Man 7(5):267–270

    Google Scholar 

  • Bruera E, Hui D, Dalal S, Torres-Vigil I et al (2013) Parenteral hydration in patients with advanced cancer: a multicenter, double-blind, placebo-controlled randomized trial. J Clin Oncol 31(1):111–118

    Google Scholar 

  • Chua TP, Harrington D, Ponikowski P et al (1997) Effects of dihydrocodein on chemosensitivity and exercise tolerance in patients with chronic heart failure. J Am Coll Cardiol 29:147–152

    Google Scholar 

  • Currow DC, Coughlan M, Fardell B, Cooney NJ (1997) Use of ondasentron in palliative medicine. J Pain Symptom Manage 13:302–307

    Google Scholar 

  • Currow DC, Quinn S, Agar M et al (2015) Double-blind, placebo-controlled, randomized trial of octreotide in malignant bowel obstruction. J Pain Symptom Manage 49(5):814–821

    Google Scholar 

  • Davis K, Attie M (1991) Management of severe hypercalcaemia. Crit Care Clin 7:175–190

    Google Scholar 

  • Drossman DA (2006) Rome III: The Functional Gastrointestinal Disorders, 3rd ed. Degnon Associates Inc, McLean, VA

    Google Scholar 

  • Drossman et al (1990) Identificationof subgroups of functiomal gastrointestinal disorders. Gatroenterol Int 3:159–172

    Google Scholar 

  • Emanuel EJ, Fairclough DL, Slutsman J, Emanuel LL (2000) Understanding economic and other burdens of terminal illness: experience of patients and their caregivers. Ann Intern Med 132:451–459

    Google Scholar 

  • Evans KC, Bahnzett RB, Adams L (2002) BOLD fMRI identifies limbic, paralimbic, and cerebellar activation during air hunger. J Neurophysiol 88:1500–1511

    Google Scholar 

  • Fainsinger R, McEachern T, Hanson J (1991) Symptome control during the last week of life in a palliative care unit. J Palliative Care 7:5–11

    Google Scholar 

  • Fallon B (1998) Nausea and vomiting unrelated to case treatment. In: Berger AM, Portenoy RK, Weissman DE (eds) Principle and Practice of Supportive Oncology. Lippincott Williams and Wilkins, Philadelphia, pp 179–190

    Google Scholar 

  • Fernandez F, Levy J, Mansell P (1989) Management of delirium in terminally ill AIDS patients. Int J Psychiat Med 19:165–172

    Google Scholar 

  • Feuer DJ, Broadley (1999) Systematic review of corticosteroids for the resolution of malignant bowel obstruction in advanced gynaecological and gastrointestinal cancers. Ann Oncol 10:1035–1040

    Google Scholar 

  • Gaginella TS, Bris P (1978) Laxatives: an update on the mechanism of action. Life Sci 23:1001–1010

    Google Scholar 

  • George J, Crawford D, Lewis T et al (1990) Percutaneous endoscopic gastrostomy: a tow year experience. Med J Aust 152:17–20

    Google Scholar 

  • Glare P, Peirera G, Krsitjanson LJ et al (2001) Systematic review of the efficacy of antiemetic in the treatment of nausea in patients with far-advanced cancer. Support Care Cancer 12:432–440

    Google Scholar 

  • Gonzales-Rosales F, Walsh D (1997) Intractable nausea and vomiting due to gastrointestinal mucosal metastases relieved by tetrahydrocannabinol. 14(5):311–314

    Google Scholar 

  • Hardy J, Daly S, McQuade B et al (2002) A double-blind, randomized parallel group, multinational, multi-centre study comparing ondansetron 24 mg p.o. with placebo and metoclopramide 10 mf tds p.o. in the treatment of opioid induced nausea and emesis in cancer patients. Support Care Cancer 10:331–336

    Google Scholar 

  • Heath DA (1989) Hypercalcemia of malignancy. BMJ 298:1468–1469

    Google Scholar 

  • Hestermann U, Backenstrass M, Gekle I et al (2009) Validation of a German version of the Confusion Assessment Method for delirium detection in a sample of acute geriatric patients with a high prevalence of dementia. Psychopathology 42(4):270–276

    Google Scholar 

  • Higgins I McCarthyM (1989) Measuring Symptoms in terminal cancer: are pain and dyspnea controlled? J R Soc Med 82:264–266

    Google Scholar 

  • Holmes S (1989) Use of a modified symptom distress scale in assessment of the cancer patient. Int J Nurs Stud 26:69–7932

    Google Scholar 

  • Inouye B, Bogardus Jr S, Charpentier P et al (1999) A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med 340(9):669–676

    Google Scholar 

  • Johnson MJ, MC Donagh TA, Harkness A, et al (2001) Morphine for the relief of breathlessness in patients with chronic heart failure-a pilot study. Eur J Heart Fail 4:753–756

    Google Scholar 

  • Kovacs C, MacDonald S, Chik C, Bruera E (1995) Hypercalcemia of malignancy in the palliative care patient: a treatment strategy. J Pain Symptom Manage 10:224–232

    Google Scholar 

  • Lawlor P, Gagnon B, Mancini I et al (2001) The occurrence, causes and outcome of delirium in advanced cancer patients: a prospective study. Arch Int Med 160:786–794

    Google Scholar 

  • Leupoldt A, Dahme B (2005) Cortical substrates for the perception of dyspnea. Chest 128(1):345–354

    Google Scholar 

  • Light RW, Muro JR, Sato RI, et al (1989) Effects of oral morphine on breathlessness and exercise tolerance in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 139:126–133

    Google Scholar 

  • Lowler P (2002) Delirium and dehydration: Some fluid for thought? Support Care Cancer 195:835–839

    Google Scholar 

  • MacKintosh D (2016) Olanzapine in the Management of Difficult to Control Nausea and Vomiting in a Palliative Care Population: A Case Series. J Palliat Med 19:87–90

    Google Scholar 

  • Major P (2001) Use of zeolendroic acid, a novel, highly potent bisphosphonate, for treatment of hypercalcemia of malignancy. Oncologist 7:481–491

    Google Scholar 

  • Manning HL, Schwartzstein RM (1995) Pathophysiology of dyspnea. N Engl J Med 333:1547–1553

    Google Scholar 

  • Massie M, Holland J, Glass E (1983) Delirium in terminally ill cancer patients. Am J Psychiatry 140:1048–1050

    Google Scholar 

  • Mazzocatto C, Buclin T, Rapin CH (1999) The effects of morphine on dyspnea on ventilator function in elderly patients with advanced cancer: a randomized double-blind controlled trial. Annal Oncol 10:1511–1014

    Google Scholar 

  • Menza M, Murray G, Holmes V (1988) Controlled study of extrapyramidal reactions in the management of delirious medically ill patients: Intravenous Haldol versus Haldol plus benzodiazepines. Heart Lung 17:2318–2341

    Google Scholar 

  • Mercadante S, Avola G, Maddaloni S et al (1996) Octreotide prevents the pathological alterations of bowl obstruction in cancer patients. Support Care Cancer 4:393–394

    Google Scholar 

  • Mercadante S, DE Conno F, Ripamonti C (1995) Propofol in terminal care. J Pain Symptom Manage 10:639–642

    Google Scholar 

  • Mercadante S, Spoldi, Caraceni A et al (1993) Octreotide in relieving gastrointestinal symptoms due to bowel obstruction. Palliat Med 7:295–299

    Google Scholar 

  • Morita T, Hyodo I, Yoshimi T et al (2004) Incidence and underlying etiologies of bronchial secretion in terminally ill cancer patients: a multicenter, prospective, observational study. J Pain symptom Manage 27:533–539

    Google Scholar 

  • Morita T, Tsunoda J, Inoue S et al (1999) Perception and decision-making on rehydration of terminally ill cancer patients and family members. Am J Hosp Palliat Care 16:509–516

    Google Scholar 

  • Moyle J (1995) The use of propofol in palliative medicine. J Pain Symptom Manage10:643–646

    Google Scholar 

  • Muers MF, Round CE (1993) Palliation of symptoms in non-small cell lung cancer: a study by the Yorkshire Regional Cancer Organization Thoracic Group. Thorax 48:339–343

    Google Scholar 

  • Nash Smyth E, Conti I, Wooldridge JE et al (2015) Frequency of skeletal-related events and associated health care resource use and costs in US patients with multiple myeloma. J Med Econ 15:1–26

    Google Scholar 

  • Nellgard P, Bojo L, Cassuto J (1995) Importance of vasoactive intestinal peptide and somatostatin for fluid loss in small bowl obstruction. Scand J Gastroenterol 30:464–469

    Google Scholar 

  • Nelville R, Fielding P, Cambria RP, Modlin I (1991) Vascular responsiveness in obstructive gut. Dis Colon Rectum 4:229–235

    Google Scholar 

  • Oliver D (1985) The use of methotrimeprazine in terminal care. BrJ Clin Pract 39:339–340

    Google Scholar 

  • Passik S, Cooper M (1999) Complicated delirium in cancer patients successfully treated with olanzapine. J Pain Symptom Manage 7:219–223

    Google Scholar 

  • Patel S, Lyons A, Hosking D (1993) Drugs used in the treatment of metabolic bone disease. Clinical pharmacology and therapeutic use. Drugs 46:594–617

    Google Scholar 

  • Pictus D, Marx MV, Weyman PJ (1988) Chronic intestinal obstruction: value of percutaneous gastrostomy tube placement. Am J Radiol 150:295–297

    Google Scholar 

  • Reuben DB, Mor V (1986) Dyspnea in terminally ill cancer patients. Chest 89:234–326

    Google Scholar 

  • Reynolds JC, Putnam PE (1992) Prokinetic agents. Gastroenterol Clin North Am 21:567–596

    Google Scholar 

  • Ripamonti C, Panzeri C, Groff L et al (2001) The role of somatostatin and octreotide in bowl obstruction: pre-clinical and clinical results. Tumori 87:1–9

    Google Scholar 

  • Sarhill N, Walsh D, Nelson K, Davis M (2001) Evaluation and treatment of cancer related fluid deficits: volume depletion or dehydration. Support Care Cancer 9:408–419

    Google Scholar 

  • Schwartz T, Massand P (2001) The role of atypical antipsychotics in the treatment of delirium. Psychosomatics 43:171

    Google Scholar 

  • Sipahimalami A, Sime RM ,Massand P (1997) Treatment of delirium with risperdon. In J Geriatric Psychopharmacol 1:24–26

    Google Scholar 

  • Srivastava M, Brito-Dellan N, Davis MP et al (2003) Olanzapine a s an antiemetic in refractory nausea and vomiting in advanced cancer. J Palliat Med 6:251–255

    Google Scholar 

  • Stark RD, Gambles SA, Lewis JA (1981) Methods to access breathlessness in healthy subjects: a critical evaluation and application to analyze the acute effects of diazepam and promethazin on breathlessness induced by exercise or by exposure to raised levels of carbon dioxide. Clin Sci (Lond) 61:429–439

    Google Scholar 

  • Stiefel F, Kornblith A, Holland J, Coyle N, Breitbart W, Weaver S, Portenoy R (1994) Delirium as a contributing factor to ›crescendo‹ pain: Three case reports. J Pain Symptom Manage; 9:44–47

    Google Scholar 

  • Thomas JR, von Guten CH (2006) Dyspnea. In: Bruera E, Higgins IJ, Ripamonti C, von Guten CH (eds) Textbook of Palliative Medicine. Oxford University Press 655–662

    Google Scholar 

  • Twycross R, Back I (1998) Nausea and vomiting in advanced cancer. Eur J Palliat Care 5:39–45

    Google Scholar 

  • Ventafridda V, Ripamonti C, Caraceni A et al (1990) The management of inoperable gastrointestinal obstruction in terminal cancer patients. Tumori 76:389–393

    Google Scholar 

  • Ventafridda V, Ripamonti C, DeConno F (1990) Symptom prevalence and control during cancer patients´ last days of life. J Palliat Care 6:7–11

    Google Scholar 

  • Wald A (2000) Constipation. Med Clin North Am 84:1231

    Google Scholar 

  • Williams SG, Wright DJ, Marshall P et al (2002) Safety and potential benefits of low dose diamorphine during exercise in patients with chronic heart failure. Heart 88:1085–1086

    Google Scholar 

  • Woodcock AA, Gross ER, Geddes DM (1981) Drug treatment of breathlessness: contrasting effects of diazepam and promethazine in pink puffers. Br Med J (Clin Re Ed) 281:343–346

    Google Scholar 

  • Zebraski SE, Kochenash SM, Raffa RB (2000) Lung opioid receptors: pharmacology and possible target for nebulized morphine in dyspnea. Lif Sci 66:2221–2231

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Leiter der Klinischen Abteilung für Palliativmedizin, Medizinische Universität Wien Allgemeines Krankenhaus Wien, Währinger Gürtel 18–20, 1090, Wien, Österreich

    Univ. Prof. Dr. Herbert Watzke

Authors
  1. Univ. Prof. Dr. Herbert Watzke
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Fana, Norway

    Stein Husebø

  2. Rankweil, Austria

    Gebhard Mathis

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer-Verlag GmbH Deutschland

About this chapter

Cite this chapter

Watzke, H. (2017). Symptomkontrolle. In: Husebø, S., Mathis, G. (eds) Palliativmedizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-49039-6_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-49039-6_5

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-49038-9

  • Online ISBN: 978-3-662-49039-6

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation